Elsevier

The Lancet Oncology

Volume 21, Issue 2, February 2020, Page e67
The Lancet Oncology

Correspondence
Levofloxacin prophylaxis in patients with myeloma

https://doi.org/10.1016/S1470-2045(19)30824-1Get rights and content

Cited by (5)

View full text